Development of an in vitro keloid scar model for identifying and testing new anti-scar therapies. - Development of an in vitro keloid scar model.

Vrije Universiteit Medisch Centrum0 个研究点目标入组 60 人开始时间: 待定最近更新: 2024年4月29日

适应症

试验速览

暂无简介。

•For keloid patients:
•- history of keloid formation: presence of at least 1 major keloid (>0.5cm)at least 6 months old, diagnosed as such by plastic surgeon specialized in scarring
•- 18 years or older and capable of giving informed consent;For healthy controls:
•- previously undergone surgery of the trunk region (thorax, abdomen) resulting in a
•normal scar at least 5cm in length
•- normal scar should be at least 6 months old
•- no abnormal scarring in medical history
•- 18 years or older and capable of giving informed consent

•- systemic illness
•- chronic use of systemic medication (e.g. corticosteroids, anti-inflammatory drugs such as aspirin)

发起方